Funding news
Thea Pharma US logo

Thea Pharma US Raises $4.0

Recently funded · $4.0M Pre-seedHospitals and Health CareUSView source

Get the full Thea Pharma US company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Lexington, Massachusetts-based Thea Pharma US has landed $4.0M in pre-seed funding, signaling fresh capital for its established portfolio of ophthalmic treatments. The U.S. subsidiary of Théa, founded in 2019, operates with a focus on the American market, aiming to deliver uncompromising eye care.

The company's offerings include seven FDA-regulated products such as Zioptan®, AcellFX™, and IYUZEH™, alongside iVIZIA dry-eye drops and eyelid hygiene solutions. This pre-seed round provides a boost for a firm already active with a range of approved products.

From the source

May 8, 2026

Thea Raises $4M Pre-seedThea, a New Castle, US-based AI-powered skincare and dermatology platform, has secured $4M in a pre-seed funding round.#AI #Skincare #Dermatology #SkinAnalysis #SkincareAI #AIAssistant #FacialAnalysis #PreSeed #Funding #Theahttps://lnkd.in/g-rriZcn

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Pre-seed rounds

Companies that recently closed a Pre-seed round.

#CompanyAmount
1
Emphere logo

Emphere

United States

$2.1M
2
Sensie logo

Sensie

United States

$582.4K
3
Joyvié Health Ltd logo

Joyvié Health Ltd

United Kingdom

$1.0M
4
FlyerPrint logo

FlyerPrint

Romania

$500.0K
5
AEON Protocol logo

AEON Protocol

$8.0M